Description
Tesofensine Research Peptide For Sale
Tesofensine is a triple monoamine reuptake inhibitor (MRI) that acts on dopamine, serotonin, and norepinephrine transporters simultaneously. Originally investigated in neurodegeneration research, tesofensine has since attracted significant interest in metabolic research due to its effects on appetite regulation and energy expenditure.
Research Overview
In published Phase 2 research, tesofensine demonstrated significant effects on body weight and metabolic markers at doses of 0.25mg–1mg daily. Its triple-mechanism action differentiates it from single-target compounds. Researchers studying obesity pathways, appetite regulation, and CNS metabolic signaling have cited tesofensine as a compound of interest.
Product Specifications
- Form: 30 oral tablets
- Purity: ≥99% (HPLC verified)
- Testing: Third-party Certificate of Analysis available
- Storage: Store at room temperature, away from moisture and light
- For research and laboratory use only — not for human consumption
For research and laboratory use only. Not intended for human consumption. Not for use in food, drug, or cosmetic products.






